Trimetazidine in the prevention of contrast‐induced nephropathy after coronary procedures
AUTOR(ES)
Onbasili, Alper O
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1955192Documentos Relacionados
- Hyperuricemia may be related to contrast-induced nephropathy after percutaneous coronary intervention
- Contrast safety in the cancer patient: preventing contrast-induced nephropathy
- Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
- Relationship between contrast-induced nephropathy and long-term mortality after percutaneous coronary intervention in patients with chronic coronary total occlusion
- Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction